← Leaderboards
Diane Renee Bielenberg
Boston Children'S Hospital
$4,392,792
Attributed
$7,595,560
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2006–25$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,595,560 · 5
By mechanism
R01$6,405,537 · 3
K01$774,090 · 1
R21$415,933 · 1
Top collaborators
- Rosalyn M Adam5 shared
- Hong Chen5 shared
Most similar at Boston Children'S Hospital
Same institution · by research overlap
- Hong Chen$23,928,447
- Timothy Tun Hla$35,188,963
- Yang Lee$76,767
Others in their field
Top investigators on “Phenotype”
- David R. Weir · University Of Michigan At Ann Arbor$239,033,262
- David Heimbrook · Leidos Biomedical Research, Inc.$213,586,034
- Constance Ann Benson · University Of California, San Diego$187,132,366
- Richard A Gibbs · Baylor College Of Medicine$184,906,270
- James E. Gern · University Of Wisconsin-Madison$141,704,104
- Garret A Fitzgerald · University Of Pennsylvania$141,348,491
Research focus
PhenotypeLymphatic VesselSignal TransductionLigandsSemaphorinsProteinsLymphangiogenesisIn VivoNeuropilin-2MolecularSiteAnimal ModelMediatingComplexFunctional DisorderPhysiologicalTissuesMouse ModelMedicalIn VitroGeneticChronicAblationLymphatic Endothelial Cells
Grant awards (17)
Controlling Neuropilin-2 Signaling to Improve Lymphatic Function$865,694
R01 · FY2025 · HL · contact PI
Molecular Mechanisms Regulating Neuropilin 2 in Lymphangiogenesis$763,788
R01 · FY2022 · HL · contact PI
Molecular Mechanisms Regulating Neuropilin 2 in Lymphangiogenesis$765,490
R01 · FY2021 · HL · contact PI
Molecular Mechanisms Regulating Neuropilin 2 in Lymphangiogenesis$779,178
R01 · FY2020 · HL · contact PI
The neuropilin 2 axis in smooth muscle contractility$457,814
R01 · FY2020 · DK
Molecular Mechanisms Regulating Neuropilin 2 in Lymphangiogenesis$785,197
R01 · FY2019 · HL · contact PI
The neuropilin 2 axis in smooth muscle contractility$457,814
R01 · FY2019 · DK
The neuropilin 2 axis in smooth muscle contractility$497,354
R01 · FY2018 · DK
The neuropilin 2 axis in smooth muscle contractility$497,354
R01 · FY2017 · DK
The neuropilin 2 axis in smooth muscle contractility$535,854
R01 · FY2016 · DK
Targeting Neuropilin 2 with Semaphorin 3F during Pancreatic Carcinoma Progression$227,070
R21 · FY2012 · CA · contact PI
Targeting Neuropilin 2 with Semaphorin 3F during Pancreatic Carcinoma Progression$188,863
R21 · FY2011 · CA · contact PI
Semaphorin 3F: Structure, Function, and Anti-Metastatic Activity$159,300
K01 · FY2010 · CA · contact PI
Semaphorin 3F: Structure, Function, and Anti-Metastatic Activity$159,300
K01 · FY2009 · CA · contact PI
Semaphorin 3F: Structure, Function, and Anti-Metastatic Activity$159,300
K01 · FY2008 · CA · contact PI
Semaphorin 3F: Structure, Function, and Anti-Metastatic Activity$159,300
K01 · FY2007 · CA · contact PI
Semaphorin 3F: Structure, Function, and Anti-Metastatic Activity$136,890
K01 · FY2006 · CA · contact PI